We reviewed the clinical characteristics of 40 DLBCL patients with leukemic phase identified by flow cytometry and analyzed BCL2 and MYC aberrations by fluorescence in situ hybridization. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.